Michael Bartl

Universitätsmedizin Göttingen

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Collaborators (4)

Stefan Sondermann

University of Lübeck

Sebastian Johannes Mueller

Klinikum Stuttgart

Brit Mollenhauer

Jawed Nawabi

Charité - Universitätsmedizin Berlin

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Bartl

Research Interests

Explore related searches

Contact this professor

Articles (13)

Collaborators (4)

Stefan Sondermann

Sebastian Johannes Mueller

Brit Mollenhauer

Jawed Nawabi

Make your next move.

Michael Bartl

Research Interests

Explore related searches

Contact this professor

Articles (13)

Author Correction: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease

Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset

Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease

Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis

Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI

Restless Legs Syndrom

Patterns of acute ischemic stroke and intracranial hemorrhage in patients with COVID-19

Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up

Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease

Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.

Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale in Two Independent Cohorts with Early Parkinson’s Disease

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Collaborators (4)

Stefan Sondermann

Sebastian Johannes Mueller

Brit Mollenhauer

Jawed Nawabi

Make your next move.